Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jul 27, 2015 at 10:59 AM EDT

Aimmune Prepares For IPO By Setting Expected Price Range

ThinkstockAimmune Therapeutics, Inc. filed an S-1 form with the Securities and Exchange Commission (SEC) for its initial public offering. The…

Chris Lange | Jul 27, 2015 at 8:21 AM EDT

Short Sellers Run For Cover From Major Pharma

ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…

Chris Lange | Jul 27, 2015 at 7:57 AM EDT

Short Sellers Back Off Major Biotechs

ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of…

Douglas A. McIntyre | Jul 27, 2015 at 4:44 AM EDT

Teva Will Buy Allergan Generics for $40.5 Billion

In a deal which had been anticipated, Teva Pharmaceutical Industries (NYSE: TEVA) announced it would buy Allergan Generics in a…

Jon C. Ogg | Jul 26, 2015 at 10:21 AM EDT

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings…

Jon C. Ogg | Jul 24, 2015 at 9:45 AM EDT

Is This the End of Sunesis?

Sunesis Pharmaceuticals probably wishes that this Friday never happened, as shares were down almost 70% just after the opening bell.

Chris Lange | Jul 24, 2015 at 9:10 AM EDT

Are AbbVie Earnings Enough?

AbbVie reported better-than-expected second-quarter financial results Friday before the markets opened.

Paul Ausick | Jul 24, 2015 at 8:25 AM EDT

Why Biogen Shares Are Tumbling After Earnings Report

Biogen reported mixed second-quarter 2015 results before markets opened Friday morning.

Chris Lange | Jul 23, 2015 at 1:55 PM EDT

What to Look for in Biogen Earnings Report

Biogen is scheduled to release its second-quarter financial results before the markets open on Friday.

Jon C. Ogg | Jul 23, 2015 at 1:45 PM EDT

Can Cara Ultimately Get Its Drug Approved?

Cara Therapeutics may not be a household name, but its shares scream higher on Thursday after clearing Phase 2 trial…

Chris Lange | Jul 23, 2015 at 1:25 PM EDT

What to Expect From AbbVie Earnings

Abbvie is scheduled to report its second-quarter financial results before the markets open Friday.

Chris Lange | Jul 23, 2015 at 11:05 AM EDT

How Much New Eli Lilly Product Launches Boosted the Bottom Line

Eli Lilly reported better-than-expected second-quarter earnings Thursday before the markets opened.

Chris Lange | Jul 23, 2015 at 10:55 AM EDT

Why Bristol-Myers Squibb Solid Earnings Beat Failed to Impress

Bristol-Myers Squibb released better-than-expected second-quarter financial results before the markets opened Thursday.

Chris Lange | Jul 23, 2015 at 9:50 AM EDT

Celgene Earnings Beat and Updated Guidance

Celgene released better-than-expected second-quarter earnings report Thursday before the markets opened.

Chris Lange | Jul 22, 2015 at 2:00 PM EDT

Illumina Gets a Reset

Illumina reported mixed second-quarter financial results on Wednesday before the markets opened.

1 … 254 255 256 257 258 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Aimmune Prepares For IPO By Setting Expected Price Range

Short Sellers Run For Cover From Major Pharma

Short Sellers Back Off Major Biotechs

Teva Will Buy Allergan Generics for $40.5 Billion

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Is This the End of Sunesis?

Are AbbVie Earnings Enough?

Why Biogen Shares Are Tumbling After Earnings Report

What to Look for in Biogen Earnings Report

Can Cara Ultimately Get Its Drug Approved?

What to Expect From AbbVie Earnings

How Much New Eli Lilly Product Launches Boosted the Bottom Line

Why Bristol-Myers Squibb Solid Earnings Beat Failed to Impress

Celgene Earnings Beat and Updated Guidance

Illumina Gets a Reset

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

A $620,000 Portfolio That Pays More Than the Average Social Worker's Salary

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

Health and Healthcare Articles

All Health and Healthcare Articles

Aimmune Prepares For IPO By Setting Expected Price Range

Short Sellers Run For Cover From Major Pharma

Short Sellers Back Off Major Biotechs

Teva Will Buy Allergan Generics for $40.5 Billion

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Is This the End of Sunesis?

Are AbbVie Earnings Enough?

Why Biogen Shares Are Tumbling After Earnings Report

What to Look for in Biogen Earnings Report

Can Cara Ultimately Get Its Drug Approved?

What to Expect From AbbVie Earnings

How Much New Eli Lilly Product Launches Boosted the Bottom Line

Why Bristol-Myers Squibb Solid Earnings Beat Failed to Impress

Celgene Earnings Beat and Updated Guidance

Illumina Gets a Reset

A $620,000 Portfolio That Pays More Than the Average Social Worker’s Salary

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

Featured Reads

A $620,000 Portfolio That Pays More Than the Average Social Worker's Salary

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds